Santiago1000
Big news from Eli Lilly 🚀 Their weight-loss drug tirzepatide just made waves by reducing the risk of developing Type 2 diabetes by a whopping 94% in prediabetic adults who are obese or overweight. 💉👏 No surprise, $LLY (Eli Lilly & Co) shares jumped 2.90% on this promising update. This breakthrough could be a game-changer in the fight against diabetes and obesity! $NVO (Novo-Nordisk A/S SPONS ADR) $HIMS (Hims & Hers Health Inc) $XLF $JNJ (Johnson & Johnson)